Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure

OBJECTIVE: Monitoring B-type natriuretic peptide (BNP) to guide pharmacotherapy might improve survival in patients with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF). However, the cost-effectiveness of BNP-guided care is uncertain and guidelines do not u...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Mohiuddin, Syed, Reeves, Barnaby, Pufulete, Maria, Maishman, Rachel, Dayer, Mark, Macleod, John, McDonagh, Theresa, Purdy, Sarah, Rogers, Chris, Hollingworth, William
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2016
Assuntos:
Cardiovascular Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223729/
https://ncbi.nlm.nih.gov/pubmed/28031211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-014010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares